Largest biotech companies by net assets
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
ImmunityBio has the lowest figure of the 24 biotech companies ranked by net assets, at -HUF 168.4B, followed by Halozyme Therapeutics (HUF 16.4B) and Kodiak Sciences (HUF 53B). Figures as of 18 Nov 2026, 19:49 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 24
- Lowest
- ImmunityBio-HUF 168.4B
- Median
- HUF 677.7B
- Combined market value
- HUF 281.56T
- Countries
- 5
Market values as of .
All countries▾
All sectors▾
Biotech▾
| # | Company | Net assets ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ImmunityBioIBRX · Health Care | -HUF 168.4B | HUF 2.42T | HUF 2,272.98 | 7.91% up | 193% up | ||
| 2 | Halozyme TherapeuticsHALO · Health Care | HUF 16.4B | HUF 3.69T | HUF 32,350.15 | 0.18% up | 37% up | ||
| 3 | Kodiak SciencesKOD · Health Care | HUF 53B | HUF 2.13T | HUF 32,548.58 | 0.07% down | 396% up | ||
| 4 | Adaptive BiotechnologiesADPT · Health Care | HUF 73.6B | HUF 1.55T | HUF 9,546.19 | 0.42% down | 88% up | ||
| 5 | Scholar Rock HoldingSRRK · Health Care | HUF 82.6B | HUF 1.95T | HUF 15,979.86 | 5.35% up | 14% up | ||
| 6 | Twist BioscienceTWST · Health Care | HUF 159.1B | HUF 2.68T | HUF 39,271.63 | 4.21% up | 340% up | ||
| 7 | CG OncologyCGON · Health Care | HUF 253.2B | HUF 2.41T | HUF 26,996.51 | 1.63% up | 85% up | ||
| 8 | ImmunovantIMVT · Health Care | HUF 286.9B | HUF 2.31T | HUF 11,171.43 | 0.03% down | 43% up | ||
| 9 | Krystal BiotechKRYS · Health Care | HUF 410.4B | HUF 3.13T | HUF 105,586.88 | 5.10% up | 46% up | ||
| 10 | Kymera TherapeuticsKYMR · Health Care | HUF 531.5B | HUF 3.48T | HUF 40,757.23 | 0.33% down | 87% up | ||
| 11 | Revolution MedicinesRVMD · Health Care | HUF 548.9B | HUF 11.67T | HUF 53,969.47 | 1.41% down | 131% up | ||
| 12 | CRISPR TherapeuticsCRSP · Health Care | HUF 646.7B | HUF 1.33T | HUF 13,695.10 | 1.37% up | 21% down | ||
| 13 | RepligenRGEN · Health Care | HUF 708.7B | HUF 3.69T | HUF 57,648.98 | 5.64% up | 5% up | ||
| 14 | Bio-TechneTECH · Health Care | HUF 709.4B | HUF 3.85T | HUF 24,489.67 | 0.21% up | 26% up | ||
| 15 | ExelixisEXEL · Health Care | HUF 727.3B | HUF 5.63T | HUF 23,069.69 | 0.09% up | 63% up | ||
| 16 | VaxcytePCVX · Health Care | HUF 903.6B | HUF 3.12T | HUF 19,681.24 | 1.53% down | 22% up | ||
| 17 | Neurocrine BiosciencesNBIX · Health Care | HUF 1.09T | HUF 5.56T | HUF 54,972.21 | 1.54% down | 20% up | ||
| 18 | QiagenQGEN · Health Care | HUF 1.27T | HUF 3.45T | HUF 16,688.17 | 0.31% down | 12% up | ||
| 19 | argenxARGX · Health Care | HUF 2.46T | HUF 19.96T | HUF 317,463.91 | 0.43% down | 4% up | ||
| 20 | ModernaMRNA · Health Care | HUF 2.91T | HUF 26.98T | HUF 66,677.82 | 4.18% down | 755% up | ||
| 21 | AmgenAMGN · Health Care | HUF 2.91T | HUF 80.69T | HUF 149,182.40 | 3.18% down | 34% up | ||
| 22 | BiogenBIIB · Health Care | HUF 6.14T | HUF 12.44T | HUF 84,130.66 | 0.31% down | 49% up | ||
| 23 | BioNTechBNTX · Health Care | HUF 7.18T | HUF 6.96T | HUF 28,090.10 | 1.63% down | 16% down | ||
| 24 | Gilead SciencesGILD · Health Care | HUF 7.64T | HUF 70.49T | HUF 56,834.67 | 0.80% down | 33% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Net assets is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 336.5 HUF).
Questions and answers
Which biotech companies have the lowest net assets?
ImmunityBio (-HUF 168.4B), Halozyme Therapeutics (HUF 16.4B) and Kodiak Sciences (HUF 53B) have the lowest net assets of the 24 biotech companies ranked here as of 18 Nov 2026, 19:49 UTC.
How many biotech companies are in this ranking?
24 are ranked by net assets.
What are these biotech companies worth together?
The 24 biotech companies ranked by net assets have a combined market value of HUF 281.56T as of 18 Nov 2026, 19:49 UTC.
What does ranking by net assets measure?
Shareholders' equity at the end of the latest fiscal year: what the company owns less what it owes. A negative figure means it owes more than it owns.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest biotech companies by net assets”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=net-assets
Underlying data: Yahoo Finance; SEC EDGAR.